Investigational Compound Retatrutide (also called GLP-3 or "reta") is in Phase 3 clinical trials
Take two capsules daily, ideally before a meal
However, even small increases in GLP-1 levels achieved by enhanced secretion or slowed degradation can have significant effects on glucose homeostasis, appetite regulation, and gastrointestinal motility
Common Concerns After GLP-1 Weight Loss Rapid weight loss can reduce fat volume and skin elasticity faster than the body can adapt, leading to concerns such as: Facial hollowing or a tired, aged appearance (Ozempic face) Loose or sagging skin of the face, neck, arms, abdomen, or thighs Deflated breasts or changes in breast shape Loss of body contour and definition Crepey or lax skin texture Our approach focuses on restoring volume, tightening skin, and refining contours, while maintaining natural, balanced results
Technological advancements in delivery systems, including prefilled pens and auto-injectors, have significantly improved patient convenience and treatment adherence
Secher, Jelsing, Baqueror)